Citicoline as Neuroprotector in Preterm

Phase 3

Recruiting

• Conditions: Pre-Term
• Interventions: Drug: Citicoline; Drug: Placebo oral tablet

• Registration Number: NCT03966170
• Lead Sponsor: Sherief Abd-Elsalam

Brief Summary

Citicoline as neuroprotector in preterm

Detailed Description

Efficacy of Citicoline as neuroprotector in preterm; A randomized controlled trial.

Study Timeline

• Status Verified: 2019-05
• Study Start: 2019-05-01
• Study First Submitted: 2019-05-24
• Study First Submitted QC: 2019-05-24
• Last Update Submitted: 2019-05-24
• Study First Posted: 2019-05-29
• Last Update Posted: 2019-05-29
• Primary Completion: 2028-11
• Study Completion: 2028-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Preterm on CPAP or ventilator

Read More

Exclusion Criteria

• Multiple congenital anomalies

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Citicoline	Citicoline	Citicoline as neuroprotector
Placebo drug	Placebo oral tablet	Placebo

Primary Outcome Measures

Name	Time	Method
Number of children with affection of the brain	6 months	Number of children with affection of the brain

Trial Locations

Locations (1)

Sherief Abd-Elsalam; 🇪🇬 Tanta, Egypt